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Abstract 
Objectives: To assess clinical follow-up data over 24 months using the standardized tined lead 
implantation technique, comparing the use of the curved vs straight stylet. 
 
Patients and methods: Single tertiary center, prospective study (August 2013 - June 2015)  involving 
40 patients with overactive bladder and 15 with non-obstructive urinary retention refractory to first-
line treatment. Primary outcome: successful tined lead procedure; intention to treat analysis at 12 
and 24 months. Secondary outcome: number of optimal electrode configurations during 
programming. Statistical analysis was performed by plain non-parametric tests for numeric and 
categorical data.  
 
Results: 33/35 (94%) patients implanted with the curved stylet had a successful tined lead procedure 
versus 13/20 (65%) implanted with the straight stylet (p=0.005). Intention to treat analysis at 12 and 
24 months was 94% and 91% for the patients with the curved stylet compared to 65% and 45% for 
those with the straight stylet (p=0.002 and p<0.001). 60% and 25% of the electrode configurations in 
the curved group were considered optimal and bad in comparison to 40% and 37% in the straight 
group (p<0.001). The main limitation is the non-randomized study design.  
 
Conclusions: The use of the standardized implantation technique with the curved stylet leads to 
more successful tined lead procedures, better success rates after 2-years follow-up and more 
optimal electrode configurations when compared to use of the straight stylet placement. 
 
Introduction 
In the field of urology, sacral neuromodulation (SNM) is a well-accepted, minimally invasive 
treatment for patients with overactive bladder dry (OABD) or wet (OABW), and for patients with 
non-obstructive urinary retention (NOUR), refractory to conservative treatments (1). A tined lead 
with 4 stimulation electrodes is placed through the third or fourth sacral foramen and stimulates 
sacral spinal nerves in its vicinity. Since the sacral spinal nerves are mixed nerves, it is currently still 
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unknown which nerve fibers are stimulated (autonomic vs somatic, afferent vs efferent) and what 
the mechanism of action is for specific conditions being treated with SNM (2).   
 
Success rates after 2-3y of follow-up (FU) reported by well-designed multicenter prospective studies 
vary from 50 to 76% on a “per protocol analysis” (PP) (3-6). Unfortunately, there is a lack of clarity in 
true “intention to treat” (ITT) results from those studies, incorporating all patients that were 
screened with the SNM tests. Based upon the provided study data and the percutaneous needle 
examinations and tined lead test results, intention to treat results would be around 27-61% (3-6). 
The reason for these variable and suboptimal success rates are unknown but could be related to 
patient selection or lead placement. 
 
Recently, a European panel of high volume implanters described a standardized tined lead 
implantation technique based upon live operating sessions with concomitant discussions, including 
all recently published modifications of the technique (7). The aim of the standardized technique was 
to reduce the variability in lead placement linked to the surgeon and/or the patient and to improve 
lead implantation resulting in lower activation thresholds and to improve the efficacy rates. This 
paper recommends the use of the curved stylet, as it is more flexible and may enable a more parallel 
position of the lead to the target sacral spinal nerve. Theoretically this should result in an increasing 
number of active electrode poles providing a higher likelihood for optimal effect and lower 
stimulation intensity. 
 
The primary aim of the current paper is to assess the effect of the curved vs straight stylet on long 
term clinical outcome using the standardized tined lead implantation technique. The secondary aim 
is to assess the effect of the curved vs straight stylet on the sensory response upon lead stimulation.  
 
Material and methods 
Between August 2013 and June 2015 patients eligible for SNM were screened for inclusion in this 
prospective observational study. Patients with OABD and OABW, refractory to at least two different 
antimuscarinics were eligible, as were patients with NOUR who were on clean intermittent 
catheterization. Patients with known neurological diseases or low back surgery were excluded. From 
August 2013 till March 2014, 20 patients were implanted using the straight stylet, whereas from 
April 2014 till June 2015, upon the description by Jacobs et al. (8) on the use of a curved stylet 
suggesting better outcomes, 35 consecutive patients were implanted using the curved stylet.  
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Implant procedure 
In both groups the standardized tined lead placement technique recently described in detail (7)) was 
used, with the only difference being a curved vs straight stylet inside the lead upon introduction. The 
procedural key points are: 1) ideal patient position aiming to remove the lumbar lordosis. 2) Skin 
marking of the medial edges of the foramina X-ray guided by anteroposterior (AP) view, followed by 
skin marking of the line through the lower edges of the sacroiliac joint. The intersection points of the 
lines mark at the bony level, the upper medial part of the third sacral foramen, the ideal site for lead 
entry. 3) Inserting the needle and testing for the proper response, which is characterized by an 
inward movement of the bellows upon stimulation (14 Hz – 210 µs) with amplitudes < 2mA. If this 
response was not obtained, the needle was removed and reintroduced in the same foramen and 
tested again. If after 3 needle reintroductions in the same foramen the optimal response was not 
found, another foramen was tested. In this study, the S3 left was probed first for response, followed 
by S3 right, S4 left and S4 right if no adequate answer was obtained. 4) Placing the dilator while 
making sure the tip did not protrude beyond the inner table of the sacrum, X-ray guided by lateral 
view. 5) Placing the tined lead with the use of the straight or curved stylet. Final position was 
determined by achieving a clinical response with a current stimulation of <2mA giving inward 
movement of the bellow for as much electrodes as possible. With the use of the curved stylet, 
rotation of the tip allowed for small adjustments in the lateral and AP deflection of the lead. Patients 
were tested with an external pulse generator for 3 weeks. Success upon the test was defined as 
>50% improvement in relevant parameters noted on a 3-days bladder diary. For patients with 
OABW, incontinence and urgency episodes were evaluated, for patients with OABD, 24hour 
frequency and for NOUR reduction in post void residual determined by intermittent catheterization. 
Success after 12 and 24 months was defined by asking patients if they were satisfied with the 
treatment, using a verbal analogue scale ranging from 0-100% (cutoff for satisfaction >=80%), and if 
they wished to receive add-on treatment or alternative treatments. Patients indicating that they 
were satisfied and did not wish add-on or alternative treatments were considered a success and 
were additionally asked to fill in a 3-days bladder diary to associate their perception of treatment 
with the bladder diary. Patients not satisfied or requesting add-on or alternative treatments were 
considered failures. Outside the evaluation intervals during follow up (12 and 24 months), patients 
could contact a dedicated physiotherapist in case of reduced or lack of efficacy. At those events, the 
implantable pulse generator (IPG) was read out with the clinically used N-Vision and other electrode 
configurations were programmed. Pulse duration and frequency were fixed at 210 µs and 14 Hz and 
were not changed throughout the study. 
After the pulse generator was implanted, a “sensory passport” was determined for each patient. All 
the different electrode configurations were tested, the amplitude of the perception threshold was 
noted and the patients marked the location of the perceived sensation upon stimulation on a 
dermatome chart of the perineum. The different locations were then coded as perianal, genital or 
other (leg, toe, buttock, lower back). To determine the perception thresholds, the method of limits 
was used, 4 mA was the upper limit. If no sensation was reported at 4 mA, this configuration was 
noted as “not perceived”, since these high thresholds jeopardize battery longevity.  
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Currently, it is not known whether the sensation upon stimulation in a specific location is associated 
with higher success in individual patients. However, patients with perianal and genital sensations 
less often experience uncomfortable stimulation (9), are less likely to require reprogramming (10) 
and generally tend to do better (11), in comparison to patients with sensations down the leg or 
buttocks. Therefore, perianal and genital sensation were considered prognostically good, whereas 
“other” or “not perceived” were considered bad. 
 
Statistical analyses 
All numerical data are presented as mean with standard deviation. Categorical data are presented as 
a percentage. Treatment success rates are given both on PP and ITT. Statistical significance testing 
was performed using Mann-Whitney U test (MWU) or Friedman test with post-hoc analysis using 
Wilcoxon signed rank test for numerical variables, and chi-square test for categorical variables. All 
analyses were done using IBM SPSS Statistics 23®. All statistical tests were two-tailed and were 
conducted with type I error probability of 0.05. 
 
Ethical approval 
This study was approved by the committee for Medical Ethics UZA-UAntwerp (14/50/526). 
 
Results 
Outcome 
The study population consisted of 42 female (76%) and 13 male (24%) patients. Mean age was 51.7 
+/- 17.0 years (range 18-79 years); 6 patients had OABD (11%); 34 OABW (62%) and 15 NOUR (27%). 
Baseline frequency in OABD was 16.5 +/- 3.6 voids/24h; baseline urgency incontinence in OABW was 
4.4 +/- 2.7 episodes/24h. All patients with NOUR were on aseptic intermittent self-catheterization 3-
5x/24h. There was no difference in age (MWU; p=0.82), sex (Chi2; p=0.67), indication (Chi2; p=0.67) 
or baseline frequency and incontinence (MWHU; p>0.23) between the curved and straight group. 
At the end of the test phase, success rates were significantly higher in the curved group, i.e. 94% in 
the curved vs 65% in the straight group (Chi²; p=0.005) (table 1). These patients received an IPG and 
were followed up. At 12 and 24 months, success rates were significantly higher in the curved vs 
straight group (Chi²; p=0.002) (table1). At 24 months, success in the curved group was 91% on ITT 
analysis compared to 45% in the straight group (Chi²; p<0.001) (table1). Subjective success at 12 and 
24 months (being satisfied and not requesting additional/alternative treatment) was well associated 
with the changes in the bladder diary data. Table 2 illustrates the data from the bladder diaries from 
OABW patients reporting success at 24 months, showing maintenance of the therapeutic effect.  
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Tined lead implantation (placement) 
The tined lead was placed in S3 left in 37%, S3 right in 44%, S4 left in 13% and S4 right in 6%. The 
foraminal level (S3 vs S4) or the side (left or right) was not related to outcome (Chi2; p=0.70).  The 
mean amplitude of the sensory threshold was not different between the straight (1.9 +/- 1.2 mA) 
and curved group (1.8 +/- 1.0 mA) (MWU; p=0.826). The monopolar configurations had significantly 
lower sensory thresholds than its corresponding bipolar configurations (Friedman test, Wilcoxon 
signed rank test; p<0.01). The full data are shown in table 3. The location where the different 
electrode configurations were perceived was different between both groups (Chi2; p=0.003). In the 
curved group 53% of the configurations were perceived at the anus, compared to 40% in the straight 
group. Genital sensation was reported by 23% in both the curved and straight group. However, in 
the curved group only 19% was perceived at the “other” location (leg, toe, buttock, lower back), 
compared to 31% in the straight group.  
From a clinical perspective, the most ideal stimulation would be perceived at the perianal or genital 
region with a stimulation amplitude <2mA; suboptimal would be perianal or genital perception and 
stimulation amplitude >=2mA but <=4mA; bad stimulation would be >4mA or perception at “other” 
locations. Comparing these clinical relevant parameters showed significant differences in favour of 
the curved group (Chi²; p<0.001). The data are presented in table 4. 
During SNM treatment, patients may experience episodes of reduced/lack of efficacy, which can be 
solved by troubleshooting. The first step is changing the electrode configurations, assuming the 
patient has several “optimal configurations”. Table 5 lists the percentage of patients broken down in 
relation to the number of possible “optimal configurations” and shows that more patients with a 
curved lead have more backup configurations. The table indirectly also shows that 38% in the 
straight group and 15% in the curved group have less than 4 optimal configurations.  
 
Discussion 
SNM is a well-accepted, minimally invasive treatment for patients with OABD, OABW and NOUR 
refractory to conservative treatments (1). A lead with 4 stimulation electrodes is placed through the 
third or fourth sacral foramen and stimulates sacral spinal nerves in its vicinity. Initially, the test 
stimulation procedure involved insertion of a needle and temporary lead (insulated wired) for a 3 to 
7 days test period. If test stimulation was favorable the insulated wire was removed, and a new lead 
was placed in the sacral foramen under direct vision, after surgically opening the sacral area. Since 
the lead which was placed during the test period differed from the lead used when implanting the 
IPG, efficacy rates are reported as PP. The latter, making comparison with other treatments for 
patients with OABD, OABW and NOUR, reporting efficacy rates as ITT, more difficult. In 2002, a 
percutaneous approach was described using a self-anchoring tined lead. This allowed for a less 
invasive lead implantation technique as well as maintaining the lead used in the test procedure 
when placing the definitive IPG.  
Despite this technical improvement efficacy rates have remained similar, although good 
comparisons are hampered by how the results are reported. ITT results of well-designed multicenter 
prospective studies vary between 27 to 61% for the different placement techniques (3-6) . 
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Recently, a standardized tined lead implantation technique was described aiming to reduce the 
variability in lead placement linked to the surgeon and/or the patient and to improve lead 
placements to the target nerve, which however is currently still unknown, resulting in lower 
activation thresholds and improved efficacy rates (7). The data presented here are the first reporting 
on the efficacy using the standardized technique in the field of urology. Using the standardized tined 
lead placement technique with the curved and straight stylet, our study shows an ITT of 91 and 45%, 
respectively. The straight stylet data are in line with published data (3-6, 12-14), but the curved 
stylet data are clearly higher than previously described. Since patient screening was the same 
throughout the study, patient selection seems unlikely to explain the differences. Furthermore, the 
demographic characteristics of this study are in line with those previously reported, although our 
patients seem a little bit younger.  
The higher efficacy rates presented in this manuscript with the curved stylet are most probably 
related to the implant technique and the curved design of the lead, making small adjustments in 
lead placement possible. Only one study also reported efficacy rates around 90% (15). Although the 
authors addressed patient selection as the main reason for this success, they probed the foramina 
up to 4 times, to be sure to obtain an optimal response upon needle placement. This systematic 
procedure for the tined lead implantation is similar to what is reported in the current study and may 
explain the similar success rates.  
Our results show no difference in outcome between S3 and S4. A similar observation was found in a 
study reporting on the outcome of SNM for faecal incontinence (16). A lead is implanted in S4, 
instead of S3,  when the best bellows response upon lead stimulation is elicited at this location. This 
could be explained by the fact sacral spinal nerves are mixed nerves and show a great variability in 
the functional distribution (17). Therefore, the foraminal level seems less important than the 
placement inside a foramen leading to an adequate bellows response upon stimulation. A 
randomized controlled trial comparing S3 vs S4 placement would be interesting to evaluate whether 
both placement in both levels are equivalent in clinical outcome. 
In 2014 Jacobs et al. (8) published upon the use of a curved stylet inside the lead, making the lead 
curved and therefore more controllable to direct its position. They showed that the lead placement 
with the curved stylet was superior to with the straight one in terms of motor thresholds to evoke a 
motor response upon stimulation and the number of electrodes per patients that evoked such 
responses (8). They suggested that the use of the curved stylet could lead to more optimal lead 
positions, lower stimulation thresholds thus extending battery life and more programming options, 
potentially improving efficacy rates. Based upon the publication by Jacobs et al. (8), the curved stylet 
technique was introduced in our center. The hypothesis underlying the use of the curved stylet is 
that the straight stylet may not adequately follow the curvilinear course of the sacral spinal nerves 
(which run medial to lateral along the fascia of the piriformis muscle anterolateral to the sacrum) 
and may result in placement of the deeper electrodes further from the targeted nerve spinal 
nerve—resulting in higher energy needs. The curved stylet, however, may be directionally guided 
and it is probably less likely to penetrate the fascia around nerves and vessels, thereby aiding to 
achieve a natural lateral course lead during placement. Increased efficacy rates after 2 years for the 
curved (ITT 91%) vs the straight (ITT 45%) stylet in our study are in line with this hypothesis. 
Furthermore, if the lead placed with the curved stylet aligns better with the sacral nerve, more 
electrode configurations would lead to optimal sensory responses upon lead stimulation. To assess 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
this, a sensory passport was developed which consists of the sensory threshold and the location 
where the stimulation was felt by the patient (perianal/genital/other) for each electrode 
configuration. The sensory threshold is thought to reflect the distance between the stimulating lead 
electrodes and sacral spinal nerve whereas the location where the stimulation is felt reflects the 
sacral spinal nerve which is being stimulated. Based on these two parameters, optimal 
(perianal/genital <2mA), suboptimal (perianal/genital >=2 and <=4mA) and bad (>4 mA or “other”) 
electrode configurations were defined. Interestingly, when we solely compare the sensory threshold 
between the curved and straight group, no difference is found.  
The use of the curved stylet has shown to lead to lower motor response thresholds and more active 
electrodes upon stimulation during lead placement (8). Moreover, the motor response is highly 
correlated with the sensory response (18) and Gilleran et al. (19) reported a higher number of active 
electrodes during lead placement lead to lower sensory thresholds during the first programming 
session. All these facts assume a lower sensory threshold for the curved stylet. However, our results 
did not show a significant difference in sensory threshold between those implanted with curved vs 
straight stylet. As our study did not aim to determine the motor threshold or number of active lead 
electrodes during lead placement, no estimation of the proximity of the lead to the nerve can be 
made based upon motor response. This study focused on the sensory response after lead 
implantation. Since no difference was found for sensory threshold, we postulate both leads are in 
proximity of the sacral spinal nerves but the lead with the curved stylet targets more somatosensory 
nerve fibers corresponding with the perianal dermatomes and the straight stylet more often 
stimulates somatosensory nerve fibers corresponding with the dermatomes of the leg, toe, buttock 
or lower back.  
Therefore, when we also take into account the location of sensation, significantly more optimal 
configurations were seen in the curved group compared to the straight, suggesting more electrodes 
follow the target nerve more closely. The use of such a passport can be a powerful tool to assess 
lead placement and serve as a base document for future programming sessions in case of loss of 
efficacy, as reprogramming of electrode configurations occurs frequently, with mean reported 
reprogramming rates being 1,4 to 2,8 a year (15, 19-21), and often solves clinical inefficacy and 
undesirable stimulation and thereby avoiding lead revision (22, 23). Since significantly higher efficacy 
rates were found in the curved compared to the straight group, an association between the number 
of optimal electrode configurations and clinical outcome may exist. 
 
The main limitation of this study is the non-randomized design. It should be considered, however, 
that the study was originally designed as a prospective study using the standardized tined lead 
implantation technique with the straight stylet. During the recruitment phase of this study, better 
results have been published with the curved stylet so we decided to adapt our protocol using the 
curved instead of the straight stylet. Although there was no randomization but two sequential 
series, i.e. the first 20 patients underwent lead implantation with the straight stylet and the curved 
stylet was used in all remaining patients, the in- and exclusion criteria were identical for all patients 
and the implantations were performed by the same surgeon (SDW). Thus, the comparison between 
the outcomes with the curved vs straight stylet seems justified and the follow-up is fairly long with 
24 months.  
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Another limitation is the definition of success after 12 and 24 months follow up. Patient reported 
outcomes are difficult to define resulting in a wide variety of instruments (24). Furthermore, it is 
shown there’s a high association between patient reported outcome measures on quality of health 
and bladder diaries in overactive bladder patients (25). Therefore this study used, in addition to 
bladder diaries, a rather clinically oriented outcome of satisfaction with no request for alternative or 
add-on treatment defined as success. This in the authors opinion relates well with quality of life and 
compliance of treatment. Furthermore, success as defined using these criteria were well associated 
with the bladder diary data showing maintenance of the therapeutic effect. 
 
Conclusions 
This study provides two-year clinical data on the standardized tined lead implantation technique for 
SNM and compares a curved vs straight stylet placement. The group implanted with the curved 
stylet showed a significantly higher IPG implantation rate as well as long-term success rate. 
Furthermore, a sensory passport was defined showing significantly more optimal electrode 
configurations in the curved group compared to the straight group. 
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Tables 
Table 1: Outcome. 
 
* More than 50% improvement in complaints, leading to implantation of an IPG 
Abbreviations: IPG: implantable pulse generator 
 
 
 
 
 
 
 
 
  
 Curved Straight P-value 
N 35 20  
Successful test*  33 (94%) 13 (65%) Chi2; p=0.005 
Outcome 12 months after 
implantation of IPG 
33 
(PP:100%/ ITT:94%) 
12 
(PP:92% / ITT:65%) 
Chi2; p=0.002 
Outcome 24 months after 
implantation of IPG 
32 
(PP:97% / ITT: 91%) 
9 
(PP: 69% / ITT: 45%) 
Chi2; p<0.001 
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Table 2: Number of incontinence episodes/ 24h in OABW with successful test. 
 
 
 
 
 
 
 
 
Abbreviations: FU: follow up 
 
  
 Curved Straight 
   
Baseline 4.1 +/- 3.1 4.5 +/- 1.9 
End of test phase 1.0 +/- 1.5 0.8 +/- 0.8 
12 months FU 0.9 +/- 1.4 0.5 +/- 0.5 
24 months FU 1.1 +/- 1.5 0.7 +/- 0.5 
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Table 3: Mean sensory thresholds of different electrode configurations. 
 
 
  
 Curved Straight 
   
Case + 0- 1.6 +/- 0.8 1.7 +/- 1.0 
1+ 0- 2.1 +/- 1.1 2.4 +/- 1.1 
2+ 0- 1.9 +/- 0.9 2.0 +/- 1.2 
3+ 0- 1.9 +/- 1.0 2.2 +/- 1.2 
Case + 1- 1.4 +/- 0.7 1.6 +/- 0.9 
0+ 1- 2.1 +/- 1.1 2.0 +/- 1.1 
2+ 1- 1.9 +/- 0.9 1.9 +/- 1.3 
3+ 1- 1.8 +/- 0.8 2.2 +/- 1.3 
Case + 2- 1.4 +/- 0.8 1.1 +/- 0.9 
0+ 2- 1.8 +/- 0.9 1.9 +/- 1.1 
1+ 2- 2.0 +/- 1.0 1.8 +/- 1.1 
3+ 2- 2.0 +/- 1.2 1.9 +/- 1.3 
Case+ 3- 1.2 +/- 0.5 1.5 +/- 1.1 
0+ 3- 1.8 +/- 1.0 2.2 +/- 1.3 
1+ 3- 1.8 +/- 0.9 2.0 +/- 1.2 
2+ 3- 2.0 +/- 1.1 2.2 +/- 1.3 
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Table 4: Sensory passport: percentage of the possible electrode configurations considered optimal, 
suboptimal or bad. 
 
 
  
electrode configurations Curved Straight 
   
Optimal (perianal/genital <2mA) 59.7% 40.4% 
Suboptimal (perianal/genital >=2 and <=4mA) 15.0% 22.6% 
Bad (>4 mA or “other”) 25.4% 37.0% 
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Table 5: Sensory passport: percentage of patients that have numbers of optimal electrode 
configurations – cumulative percent. 
 
 
 
optimal electrode configurations Curved Straight 
>=12  39.4% 15.4% 
>=8 69.73% 30.8% 
>=4 84.8% 61.5% 
<4 100% 100% 
